Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasms, Plasma Cell × Vorinostat × Clear all

Phase

Status

Completed 3 Withdrawn 2 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 2 Wilms Tumor 1 Thrombocythemia, Essential 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Recurrence 1 Polycythemia Vera 1 Polycythemia 1 Ovarian Neoplasms 1 Neuroectodermal Tumors 1 Neoplasms, Plasma Cell 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoma, T-Cell, Cutaneous 1 Leukemia, Myeloid, Acute 1 Hepatoblastoma 1 Hematologic Diseases 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 15 Dexamethasone 13 Melphalan 12 Bortezomib 11 Filgrastim 6 Peripheral Blood Stem Cell Transplantation 5 Thalidomide 4 Prednisone 4 Lenalidomide 4 fludarabine phosphate 3 Radiotherapy 3 Mycophenolic Acid 3 Interferon-alpha 3 Doxorubicin 3 Busulfan 3 Antilymphocyte Serum 3 sargramostim 2 pomalidomide 2 isatuximab 2 fludarabine 2 daratumumab 2 Vincristine 2 Methylprednisolone 2 Idarubicin 2 Cyclosporine 2 Carmustine 2 plerixafor 1 pegfilgrastim 1 orantinib 1 epoetin beta 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01554852 2018-06-11

Myeloma XI

University of Leeds

Phase 3 Unknown

Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡